AddLife AB (publ) Just Beat EPS By 8.9%: Here's What Analysts Think Will Happen Next
Apr 30
Have your own idea? Try our Stock Screener
Swedish (OMX) Healthcare Sector Analysis
UpdatedApr 30, 2025
DataAggregated Company Financials
Companies178
- 7D5.7%
- 3M-8.7%
- 1Y0.01%
- YTD-7.5%
The Healthcare industry is up 5.7% in the last week, with Swedish Orphan Biovitrum up 10%. Overall in the last year, the industry is flat. Earnings are forecast to grow by 28% annually.
Sector Valuation and Performance
Has the Swedish Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 01 May 2025 | SEK 581.3b | SEK 223.4b | SEK 5.2b | 36x | 111.8x | 2.6x |
| Sat, 29 Mar 2025 | SEK 571.6b | SEK 220.9b | SEK 5.4b | 36.2x | 105.8x | 2.6x |
| Mon, 24 Feb 2025 | SEK 588.4b | SEK 206.2b | SEK 4.3b | 38.5x | 135.7x | 2.9x |
| Wed, 22 Jan 2025 | SEK 589.1b | SEK 202.6b | -SEK 2,463,435,869.41 | 42x | -239.1x | 2.9x |
| Fri, 20 Dec 2024 | SEK 573.1b | SEK 202.6b | -SEK 2,502,526,167.65 | 38.6x | -229x | 2.8x |
| Sun, 17 Nov 2024 | SEK 509.8b | SEK 199.9b | -SEK 2,849,689,856.45 | 37.4x | -178.9x | 2.5x |
| Tue, 15 Oct 2024 | SEK 539.1b | SEK 195.3b | -SEK 2,761,816,675.46 | 38.6x | -195.2x | 2.8x |
| Thu, 12 Sep 2024 | SEK 613.3b | SEK 200.3b | -SEK 2,805,459,044.76 | 40.2x | -218.6x | 3.1x |
| Sat, 10 Aug 2024 | SEK 573.5b | SEK 199.5b | -SEK 2,393,629,457.57 | 40.8x | -239.6x | 2.9x |
| Mon, 08 Jul 2024 | SEK 564.8b | SEK 195.7b | -SEK 3,195,314,032.76 | 37.3x | -176.8x | 2.9x |
| Wed, 05 Jun 2024 | SEK 566.7b | SEK 195.7b | -SEK 2,835,552,344.77 | 36.3x | -199.9x | 2.9x |
| Fri, 03 May 2024 | SEK 532.5b | SEK 196.1b | -SEK 3,326,882,163.38 | 36.9x | -160x | 2.7x |
| Sun, 31 Mar 2024 | SEK 527.3b | SEK 192.9b | -SEK 3,674,506,154.38 | 46x | -143.5x | 2.7x |
| Tue, 27 Feb 2024 | SEK 505.8b | SEK 191.7b | -SEK 3,873,204,956.91 | 48.9x | -130.6x | 2.6x |
| Thu, 25 Jan 2024 | SEK 549.6b | SEK 191.7b | -SEK 967,830,254.00 | 50.8x | -567.9x | 2.9x |
| Sat, 23 Dec 2023 | SEK 534.3b | SEK 191.0b | -SEK 960,279,085.00 | 47.8x | -556.4x | 2.8x |
| Mon, 20 Nov 2023 | SEK 489.3b | SEK 190.1b | -SEK 1,208,836,230.00 | 47.3x | -404.8x | 2.6x |
| Wed, 18 Oct 2023 | SEK 433.9b | SEK 184.9b | -SEK 1,976,085,302.00 | 32.7x | -219.6x | 2.3x |
| Fri, 15 Sep 2023 | SEK 454.9b | SEK 185.7b | -SEK 2,024,682,673.00 | 36.5x | -224.7x | 2.4x |
| Sun, 13 Aug 2023 | SEK 474.6b | SEK 184.3b | -SEK 1,014,174,020.00 | 41.7x | -468x | 2.6x |
| Tue, 11 Jul 2023 | SEK 475.7b | SEK 179.4b | -SEK 793,664,002.00 | 44.1x | -599.4x | 2.7x |
| Thu, 08 Jun 2023 | SEK 513.2b | SEK 179.0b | -SEK 543,106,564.00 | 41.1x | -944.9x | 2.9x |
| Sat, 06 May 2023 | SEK 530.4b | SEK 176.4b | -SEK 736,383,535.00 | 41.1x | -720.3x | 3x |
| Mon, 03 Apr 2023 | SEK 494.5b | SEK 172.5b | -SEK 1,399,898,502.00 | 35.6x | -353.2x | 2.9x |
| Wed, 01 Mar 2023 | SEK 493.0b | SEK 171.6b | -SEK 1,163,811,380.00 | 37.3x | -423.6x | 2.9x |
| Fri, 27 Jan 2023 | SEK 512.4b | SEK 166.1b | SEK 533.7m | 33.7x | 960.1x | 3.1x |
| Sun, 25 Dec 2022 | SEK 468.6b | SEK 165.7b | SEK 699.4m | 31.4x | 670x | 2.8x |
| Tue, 22 Nov 2022 | SEK 484.4b | SEK 164.6b | SEK 1.1b | 31x | 456.2x | 2.9x |
| Thu, 20 Oct 2022 | SEK 450.8b | SEK 159.7b | -SEK 242,804,819.00 | 29.5x | -1856.7x | 2.8x |
| Sat, 17 Sep 2022 | SEK 450.4b | SEK 159.4b | -SEK 112,034,488.00 | 31.2x | -4020.1x | 2.8x |
| Mon, 15 Aug 2022 | SEK 539.3b | SEK 156.8b | -SEK 359,297,300.00 | 32.3x | -1501x | 3.4x |
| Wed, 13 Jul 2022 | SEK 521.8b | SEK 153.8b | SEK 312.9m | 33.5x | 1667.3x | 3.4x |
| Fri, 10 Jun 2022 | SEK 544.2b | SEK 155.2b | SEK 382.8m | 37.1x | 1421.8x | 3.5x |
| Sun, 08 May 2022 | SEK 517.6b | SEK 152.6b | SEK 792.5m | 38.3x | 653.2x | 3.4x |
Price to Earnings Ratio
653.2x
Current Industry PE
- Investors are optimistic on the Swedish Healthcare industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 112x which is higher than its 3-year average PE of -758x.
- The industry is trading close to its 3-year average PS ratio of 2.9x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have grown 87% per year over the last three years.
- Revenues for these companies have grown 14% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Swedish Healthcare sector?
| SE Market | 2.07% | |
| Healthcare | 5.66% | |
| Life Sciences | 8.17% | |
| Healthcare Services | 6.99% | |
| Healthtech | 6.84% | |
| Biotech | 5.85% | |
| Pharma | 4.60% | |
| Medical Equipment | 4.25% | |
Industry PE
- Investors are most optimistic about the Biotech industry which is trading above its 3-year average PE ratio.
- Analysts are expecting annual earnings growth of 27.0%, which is higher than its past year's earnings decline of 3.8% per year.
Forecasted Growth
- Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 48% over the next 5 years.
- This is better than its past earnings growth rate of 14% per year.
- In contrast, the Healthtech industry is expected to see its earnings grow by 13% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| SOBI Swedish Orphan Biovitrum | SEK 293.00 | 5.5% +SEK 5.3b | 2.7% | PE25.4x | |
| MCOV B Medicover | SEK 241.50 | 13.6% +SEK 4.4b | 38.0% | PE108.1x | |
| SECT B Sectra | SEK 296.60 | 7.5% +SEK 4.0b | 35.3% | PE96.8x | |
| ALIF B AddLife | SEK 183.00 | 17.1% +SEK 3.3b | 78.4% | PE72.2x | |
| ASKER Asker Healthcare Group | SEK 85.50 | 8.6% +SEK 2.6b | n/a | PE91x |
